BOZEN, Italy, August 10 /PRNewswire/ --
- Strategic Partnership Announced With Health Robotics
Health Robotics today announced that it has signed an exclusive five-year strategic partnership with McKesson for Health Robotics' CytoCare Robot. The agreement enables McKesson to achieve its goal of safely, accurately and cost-effectively automating the preparation of Oncology I.V. admixtures.
"We are very pleased to have been chosen by Health Robotics as their exclusive CytoCare partner in our core markets of the United States and Canada", stated David Souerwine, President, McKesson Automation. "CytoCare, a-one-of-its-kind solution, represents an ideal complement to ROBOT-Rx(R) and MedCarousel(R) technologies, and our entire suite of Automation solutions."
McKesson believes that CytoCare has the potential to become the gold
standard for Oncology I.V. admixtures in North America, equally protecting
clinicians and patients. The successful installations of the CytoCare Robot
in the United States, including the
"McKesson is the ideal partner for Health Robotics in North America due to its commitment to medication safety, company stability, market footprint, world-class service infrastructure, and complementary oral medication automation technologies. I was extremely impressed to see their manufacturing and customer services operations in Pittsburgh; they are exactly what CytoCare customers need in North America: a knowledgeable, committed, resourceful, and customer-focused organization. This is precisely what Health Robotics requires at this moment in time to take CytoCare to the next level of market acceptance and customer-service focus in North America. I'm sure this is just the beginning of a long-term partnership expanding into manufacturing and other fields of I.V. Robotics Automation", stated Werner Rainer, Chairman and CEO of Health Robotics.
About Health Robotics:
Health Robotics is the global leading supplier of life-critical intra-venous medication preparation, compounding, and dispensing Robots, providing healthcare facilities in four continents with robotics technology and software automation solutions. The world-leading solutions CytoCare [hazardous IVs], i.v.STATION [non-hazardous IVs], i.v.SOFT [workflow engine] and the future development of TPNstation, have and will greatly contribute to ease global hospitals' growing pressures to improve patient safety through the effective and efficient production of sterile, accurate, and ready-to-administer IVs, to eliminate life-threatening drug-exchange errors, to decrease other medication errors and sterility risks, and to work more efficiently, increase throughput, reduce waste, and contain costs. For more information, visit http://www.health-robotics.com
McKesson Corporation, currently ranked 15th on the FORTUNE 500, is a healthcare services and information technology company dedicated to helping its customers deliver high-quality healthcare by reducing costs, streamlining processes, and improving the quality and safety of patient care. McKesson has been in continuous operation for more than 175 years, making it the longest-operating company in healthcare today. Over the course of its history, McKesson has grown by providing pharmaceutical and medical-surgical supply management across the spectrum of care; healthcare information technology for hospitals, physicians, homecare and payors; hospital and retail pharmacy automation; and services for manufacturers and payors designed to improve outcomes for patients. For more information, visit http://www.mckesson.com
For additional information, please contact: Health Robotics S.r.l. Gaspar G. DeViedma Altmanstrasse 9A, Bozen, Sud-Tyrol, I-39100 USA: +1-609-980-7976 EUROPE: +39-346-963-4934 firstname.lastname@example.org McKesson Corporation Clay Courville Vice President, Marketing +1-724-741-8111 email@example.com
|SOURCE Health Robotics|
Copyright©2009 PR Newswire.
All rights reserved